why choose us

First received: May 31, 2023

Clinical Trial: Open Label Extension Study of INBRX-101 in Adults With AATD Emphysema

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Alpha 1-Antitrypsin Deficiency

Study Type: INTERVENTIONAL


Official Title: This is a Phase 2, Single Arm, Open Label Extension Study, Evaluating the Long-Term Safety and Clinical Efficacy of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency (AATD) Emphysema.

Brief Summary: Phase 2 open label extension study to evaluate INBRX-101 in adults with AATD emphysema

Read more